Agilent Technologies and Groton Biosystems sign agreement

Agilent Technologies Inc. (Santa Barbara, California) and Groton Biosystems LLC (Boxborough, Massachusetts) recently announced an agreement to co-market solutions for the Process Analytical Technology (PAT) Initiative for the pharmaceutical industry in the United States and Canada.
PAT is a system for designing, analyzing, and controlling manufacturing by measuring critical quality and performance attributes of raw and in-process materials and processes with the goal of ensuring final product quality.
The alliance is designed to benefit biopharmaceutical customers who perform in-process and final product testing in a wide range of production segments.The agreement, expected to expand to Europe and Asia in the near future, brings together Agilent's HPLC systems with Groton Biosystems' strong online sampling products and services.